An inexpensive antidepressant proved no better than placebo for alleviating severe, persisting breathlessness from chronic obstructive pulmonary disease (COPD) or interstitial lung disease (ILD), a ...
Utility of the 70-Gene MammaPrint Assay for Prediction of Benefit From Extended Letrozole Therapy in the NRG Oncology/NSABP B-42 Trial Patients with advanced lung cancer reporting at least moderate ...
The BETTER-B clinical trial found that patients with COPD and ILDs using mirtazapine for breathlessness vs placebo had slightly increased adverse events and care use. Among patients with chronic ...
Persistent sleep disturbance may partially explain the dyspnoea often reported following hospitalisation with COVID-19 infection, according to a new study led by the Universities of Manchester and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results